References
Sato T, Nishiwaki K. Remimazolam should be antagonized by an adequate flumazenil. J Anesth. 2022. https://doi.org/10.1007/s00540-022-03117-9.
Murata H, Yokoyama A, Hara T. Remimazolam and low-dose flumazenil for awake craniotomy. J Anesth. 2022. https://doi.org/10.1007/s00540-022-03103-1.
Sato T, Nishiwaki K. Comparison of remimazolam and propofol in anesthetic management for awake craniotomy: a retrospective study. J Anesth. 2022;36(1):152–5.
Yoshida A, Kurata S, Kida K, Tsubokawa T. Anesthetic management for the sleep-awake-sleep technique of awake craniotomy using a novel benzodiazepine remimazolam and its antagonist flumazenil. JA Clin Rep. 2021;7(1):14.
Masui K. Caution!! Reappearance of remimazolam effect after a flumazenil bolus: a larger bolus of flumazenil and a lower total remimazolam clearance are higher risks. J Anesth. 2022. https://doi.org/10.1007/s00540-022-03107-x.
Acknowledgements
We thank NAI, Inc. (https://www.nai.co.jp) for English language editing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This reply refers to the comment available online at https://doi.org/10.1007/s00540-022-03117-9.
About this article
Cite this article
Murata, H., Yokoyama, A. & Hara, T. Titration of flumazenil during awake craniotomy. J Anesth 37, 166–167 (2023). https://doi.org/10.1007/s00540-022-03128-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-022-03128-6